Industry News - Tag: MHRA

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Oral contraceptive pill could soon be OTC in the UK
Premium

15 February 2021

Two applications to switch oral contraceptives from prescription-only to pharmacy (POM to P) status in the UK are now out for consultation. If they are approved, then Maxwellia’s Lovima and HRA Pharma’s Hana will become the country’s first OTC oral contraceptive pills.

Read the full story

Regulatory in brief / CBD, Norway, COVID-19

23 December 2020

The US Food and Drug Administration (FDA) has issued a number of warning letters to cannabidiol (CBD) companies, the Norwegian Medicines Agency (NoMA) is expanding the list of general-sale medicines, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued an exceptional us...

Read the full story

Regulatory in brief | opioids, pholcodine, Arthrem

23 September 2020

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced stronger warnings for prescribed and OTC medicines containing opioids, while New Zealand’s Medsafe is to reconsider a recent recommendation for pholcodine and has reached a settlement over Arthrem.

Read the full story

Regulatory in brief | Europe, global collaboration, US

28 April 2020

In response to the COVID-19 pandemic, the European Council has adopted the European Commission’s proposal to postpone by one year the date of application of the new Medical Devices Regulation, regulatory agencies around the world have stepped up global collaboration, and the US has taken action on h...

Read the full story

Regulatory in brief | France, the UK, the US

21 April 2020

In response to the COVID-19 pandemic, France has warned people to stop taking certain food supplements if they have COVID-19, the UK has issued advice on the use of ibuprofen and COVID-19, and the US has authorised the first diagnostic test for COVID-19 with at-home sample collection.

Read the full story